Vycor Medical (VYCO) Divestments (2019 - 2020)
Vycor Medical's (VYCO) quarterly Divestments came in at $9950.0 in Q3 2020, up 98.01% year-on-year from $5025.0 in Q4 2019, and up 911.58% on a QoQ basis from -$1226.0 in Q2 2020.
Vycor Medical (VYCO) Divestments (2019 - 2020) Analysis & Trends
Vycor Medical (VYCO) has 2 years of Divestments data on file, last reported at $9950.0 in Q3 2020.
- On a quarterly basis, Divestments rose 98.01% year-over-year to $9950.0 in Q3 2020; TTM through Dec 2020 was $9574.0, a N/A change from a year earlier, with the FY2020 full-year figure at $9574.0, up 289.82% from the prior year.
- Divestments for Q3 2020 stood at $9950.0, up from -$1226.0 in the prior quarter.
- Over the last five years, Divestments for VYCO reached as high as $9950.0 in Q3 2020 and fell as low as -$1226.0 in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.37 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 9,950.00 |
| Jun 30, 2020 | -1,226.00 |
| Mar 31, 2020 | 850.00 |
| Dec 31, 2019 | -40.00 |
| Sep 30, 2019 | 5,025.00 |